| Issue Date | Title | Involved Person(s) |
| 2-Dec-2023 | Wirksamkeitsforschung heute : das Beispiel Depressionsbehandlungen | Hengartner, Michael Pascal |
| 15-Nov-2023 | Antidepressants use in Italy : an ecological study of national and regional trends and associated factors | Amendola, Simone; Hengartner, Michael Pascal |
| 5-Sep-2023 | Prevalence, trends, and individual patterns of long-term antidepressant medication use in the adult Swiss general population | Amrein, Melanie A.; Hengartner, Michael P.; Näpflin, Markus; Farcher, Renato; Huber, Carola A. |
| Sep-2023 | Re: "A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder" by Strawn et al. : concerning harm-benefit ratio in a recent trial about Escitalopram for generalized anxiety disorder | Plöderl, Martin; Horowitz, Mark A.; Hengartner, Michael P. |
| 20-Jun-2023 | The government has a moral duty to help those harmed by prescribed dependence forming drugs | Davies, James; Horowitz, Mark; Montagu, Luke; Hollins, Sheila; Read, John; Hengartner, Michael, et al |
| 30-Mar-2023 | The risks of adverse events with venlafaxine and mirtazapine versus 'active placebo', placebo, or no intervention for adults with major depressive disorder : a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis | Jørgensen, Caroline Kamp; Juul, Sophie; Siddiqui, Faiza; Horowitz, Mark Abie; Moncrieff, Joanna; Munkholm, Klaus; Hengartner, Michael Pascal; Kirsch, Irving; Gluud, Christian; Jakobsen, Janus Christian |
| 2023 | Publication and citation biases in observational studies about antidepressants and suicides | Plöderl, Martin; Hengartner, Michael P. |
